Notice of Product Exclusion Extensions: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation, 13785-13786 [2021-04946]
Download as PDF
Federal Register / Vol. 86, No. 45 / Wednesday, March 10, 2021 / Notices
public in accordance with the
provisions of 5 U.S.C. 552, will be
available for website viewing and
printing in the Commission’s Public
Reference Room, 100 F Street NE,
Washington, DC 20549, on official
business days between the hours of
10:00 a.m. and 3:00 p.m. Copies of such
filing also will be available for
inspection and copying at the principal
office of FINRA.
All comments received will be posted
without change. Persons submitting
comments are cautioned that we do not
redact or edit personal identifying
information from comment submissions.
You should submit only information
that you wish to make available
publicly.
All submissions should refer to File
No. SR–FINRA–2020–041 and should be
submitted on or before March 24, 2021.
If comments are received, any rebuttal
comments should be submitted on or
before March 31, 2021.
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.75
J. Matthew DeLesDernier,
Assistant Secretary.
[FR Doc. 2021–04912 Filed 3–9–21; 8:45 am]
BILLING CODE 8011–01–P
DEPARTMENT OF STATE
[Public Notice: 11373]
Notice of Public Meeting
The Department of State will conduct
a public meeting at 9:30 a.m. on
Tuesday, April 6, 2021, by way of
teleconference. Members of the public
may participate up to the capacity of the
teleconference phone line, which will
handle 500 participants. To access the
teleconference line, participants should
call (804) 469–0625 and use participant
Code 974556036#.
The primary purpose of the meeting is
to prepare for the 8th session of the
International Maritime Organization’s
(IMO) Sub-Committee on Navigation,
Communication, and Search and Rescue
to be held remotely, April 19–23, 2021.
The agenda items to be considered
include:
—Adoption of the agenda
—Decisions of other IMO bodies
—Routing measures and mandatory ship
reporting systems
—Recognition of the Japanese regional
navigation satellite system QuasiZenith Satellite System (QZSS) and
development of performance
75 17 CFR 200.30–3(a)(12); 17 CFR 200.30–
3(a)(57).
VerDate Sep<11>2014
17:22 Mar 09, 2021
Jkt 253001
standards for shipborne satellite
navigation system receiver equipment
—Safety measures for non-SOLAS ships
operating in polar waters
—Revision of SOLAS chapters III and IV
for Modernization of the GMDSS,
including related and consequential
amendments to other existing
instruments
—Response to matters related to the
ITU–R Study Groups and ITU World
Radiocommunication Conference
—Revision of the Guidelines on places
of refuge for ships in need of
assistance (resolution A.949(23))
—Developments in GMDSS services,
including guidelines on Maritime
safety information (MSI)
—Development of global maritime SAR
services, including harmonization of
maritime and aeronautical procedures
—Biennial status report and provisional
agenda for NCSR 9
—Election of Chair and Vice-Chair for
2022
—Any other business
Please note: The Sub-Committee may
on short notice, adjust the NCSR 8
agenda to accommodate the constraints
associated with the virtual meeting
format. Any updates will be provided at
the public meeting and in advance, if
possible, to anyone who RSVPs.
Those who plan to participate may
contact the meeting coordinator, George
Detweiler, by email at
George.H.Detweiler@uscg.mil, by phone
at (202) 372–1566, or in writing at 2703
Martin Luther King Jr. Ave. SE, Stop
7418, Washington, DC 20593–7418. A
request for reasonable accommodation
should be made at the time of RSVP,
and not later than April 30. Requests
received after that date will be
considered, but might not be possible to
fulfill.
Jeremy M. Greenwood,
Coast Guard Liaison Officer, Office of Ocean
and Polar Affairs, Department of State.
[FR Doc. 2021–04982 Filed 3–9–21; 8:45 am]
BILLING CODE 4710–09–P
DEPARTMENT OF STATE
[Public Notice: 11372]
Convening of an Accountability
Review Board To Investigate the
Murder of an Animal and Plant Health
Inspection Service (APHIS) Locally
Employed (LE) Staff Member in
Tijuana, Mexico
Pursuant to Section 301 of the
Omnibus Diplomatic Security and
Antiterrorism Act of 1986, as amended
(22 U.S.C. 4831), the Department of
State convened an Accountability
PO 00000
Frm 00100
Fmt 4703
Sfmt 4703
13785
Review Board (ARB) to review the
October 2020 murder of an APHIS LE
Staff member in Tijuana, Mexico. The
ARB will examine the facts and
circumstances surrounding the incident
and submit its findings to the Secretary
of State, together with any
recommendations as appropriate. The
Department has appointed George
Staples, a retired U.S. ambassador, as
Chair of the Board. The other Board
members are retired U.S. Ambassador
Janice Jacobs, Mr. Dirk Dijkerman, Mr.
John Eustace, and Mr. Kimber Davidson.
They bring to their deliberations
distinguished backgrounds in
government service.
The Board will submit its findings
and recommendations to the Secretary
of State. The Department will report to
Congress on any recommendations
made by the Board and actions taken
with respect to those recommendations.
Anyone with information relevant to
the Board’s examination of these
incidents should contact the Board via
email promptly at ARBTijuana2021@
state.gov.
Zachary A. Parker,
Director, Office of Directives Management.
[FR Doc. 2021–05004 Filed 3–9–21; 8:45 am]
BILLING CODE 4710–10–P
OFFICE OF THE UNITED STATES
TRADE REPRESENTATIVE
Notice of Product Exclusion
Extensions: China’s Acts, Policies, and
Practices Related to Technology
Transfer, Intellectual Property, and
Innovation
Office of the United States
Trade Representative (USTR).
ACTION: Notice.
AGENCY:
In prior notices, the U.S.
Trade Representative modified the
action in the Section 301 investigation
of China’s acts, policies, and practices
related to technology transfer,
intellectual property, and innovation by
excluding from additional duties certain
medical-care products needed to
address the COVID–19 pandemic. To
support efforts to combat COVID–19, on
December 29, 2020, the U.S. Trade
Representative announced the extension
of certain product exclusions on
medical-care and/or COVID response
products and further modifications to
remove Section 301 duties from
additional medical-care and/or COVID
response products. This notice
announces the U.S. Trade
Representative’s determination to
extend those exclusions.
SUMMARY:
E:\FR\FM\10MRN1.SGM
10MRN1
13786
Federal Register / Vol. 86, No. 45 / Wednesday, March 10, 2021 / Notices
The extensions announced in
this notice will extend the product
exclusions through September 30, 2021.
U.S. Customs and Border Protection will
issue instructions on entry guidance and
implementation.
FOR FURTHER INFORMATION CONTACT: For
general questions about this notice,
contact Associate General Counsel
Philip Butler, Assistant General
Counsels Benjamin Allen or Susie Park
Hodge, or Director of Industrial Goods
Justin Hoffmann at (202) 395–5725. For
specific questions on customs
classification or implementation of the
product exclusions identified in the
Annexes to this notice, contact
traderemedy@cbp.dhs.gov.
SUPPLEMENTARY INFORMATION:
DATES:
A. Background
In the course of this investigation the
U.S. Trade Representative has imposed
additional duties on products of China
in four tranches. See 83 FR 28719 (June
20, 2018); 83 FR 40823 (August 16,
2018); 83 FR 47974 (September 21,
2018), as modified by 83 FR 49153
(September 28, 2018); and 84 FR 43304
(August 20, 2019), as modified by 84 FR
69447 (December 18, 2019) and 85 FR
3741 (January 22, 2020).
For each tranche, the U.S. Trade
Representative established a process by
which U.S. stakeholders could request
the exclusion of particular products
subject to the action. The U.S. Trade
Representative later established a
process by which U.S. stakeholders
could request the extension of particular
exclusions. Additionally, on March 25,
2020, the U.S. Trade Representative
requested public comments on possible
further modifications to remove Section
301 duties from additional medical-care
products to address the COVID–19
pandemic. 85 FR 16987 (March 25,
2020).
In light of the evolving nature of the
battle against COVID–19, on December
29, 2020, USTR announced the
extension of 80 product exclusions on
medical-care and/or COVID response
products; further modifications in the
form of 19 product exclusions to remove
Section 301 duties from additional
medical-care and/or COVID response
products; and that USTR might consider
further extensions and/or modifications
as appropriate. See 85 FR 85831 (the
December 29 notice).
B. Determination To Extend Certain
Exclusions
In light of the continuing efforts to
combat COVID–19, the U.S. Trade
Representative has determined that it is
inappropriate to allow the exclusions
VerDate Sep<11>2014
17:22 Mar 09, 2021
Jkt 253001
for certain products to lapse.
Accordingly, pursuant to sections
301(b), 301(c), and 307(a) of the Trade
Act of 1974, as amended, the U.S. Trade
Representative has determined to
extend the 99 product exclusions
included in the December 29 notice
through September 30, 2021, as
specified in the Annex to this notice.
The U.S. Trade Representative’s
decision to extend the 99 product
exclusions takes into account public
comments previously provided, and the
advice of advisory committees the
interagency Section 301 Committee.
As provided in the December 29
notice, the exclusions are available for
any product that meets the description
in the product exclusion. The U.S.
Trade Representative may continue to
consider further extensions and/or
additional modifications as appropriate.
Annex
Effective with respect to goods entered for
consumption, or withdrawn from warehouse
for consumption, on or after 12:01 a.m.
eastern daylight time on April 1, 2021, and
before 11:59 p.m. eastern daylight time on
September 30, 2021, each of the article
descriptions of headings 9903.88.62,
9903.88.63, 9903.88.64 and 9903.88.65 of the
Harmonized Tariff Schedule of the United
States are modified by deleting ‘‘March 31,
2021,’’ and by inserting ‘‘September 30,
2021,’’ in lieu thereof.
Greta Peisch,
General Counsel, Office of the United States
Trade Representative.
[FR Doc. 2021–04946 Filed 3–9–21; 8:45 am]
BILLING CODE 3290–F0–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
Qualification of Drivers; Exemption
Applications; Hearing
Federal Motor Carrier Safety
Administration (FMCSA), Department
of Transportation (DOT).
ACTION: Notice of final disposition.
AGENCY:
FMCSA announces its
decision to renew exemptions for nine
individuals from the hearing
requirement in the Federal Motor
Carrier Safety Regulations (FMCSRs) for
interstate commercial motor vehicle
(CMV) drivers. The exemptions enable
these hard of hearing and deaf
individuals to continue to operate CMVs
in interstate commerce.
PO 00000
Frm 00101
Fmt 4703
Sfmt 4703
Ms.
Christine A. Hydock, Chief, Medical
Programs Division, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA,
Department of Transportation, 1200
New Jersey Avenue SE, Room W64–224,
Washington, DC 20590–0001. Office
hours are from 8:30 a.m. to 5 p.m., ET,
Monday through Friday, except Federal
holidays. If you have questions
regarding viewing or submitting
material to the docket, contact Dockets
Operations, (202) 366–9826.
SUPPLEMENTARY INFORMATION:
FOR FURTHER INFORMATION CONTACT:
I. Public Participation
A. Viewing Comments
To view comments go to https://
www.regulations.gov. Insert the docket
number, FMCSA–2012–0154, FMCSA–
2014–0106, FMCSA–2014–0384,
FMCSA–2015–032, FMCSA–2017–0057,
or FMCSA–2018–0136 in the keyword
box, and click ‘‘Search.’’ Next, sort the
results by ‘‘Posted (Newer-Older),’’
choose the first notice listed, and click
‘‘Browse Comments.’’ If you do not have
access to the internet, you may view the
docket online by visiting Dockets
Operations in Room W12–140 on the
ground floor of the DOT West Building,
1200 New Jersey Avenue SE,
Washington, DC 20590–0001, between 9
a.m. and 5 p.m., ET, Monday through
Friday, except Federal holidays. To be
sure someone is there to help you,
please call (202) 366–9317 or (202) 366–
9826 before visiting Dockets Operations.
B. Privacy Act
[Docket No. FMCSA–2012–0154; FMCSA–
2014–0106; FMCSA–2014–0384; FMCSA–
2015–0328; FMCSA–2017–0057; FMCSA–
2018–0136]
SUMMARY:
Each group of renewed
exemptions were applicable on the
dates stated in the discussions below
and will expire on the dates provided
below.
DATES:
In accordance with 5 U.S.C. 553(c),
DOT solicits comments from the public
to better inform its rulemaking process.
DOT posts these comments, without
edit, including any personal information
the commenter provides, to
www.regulations.gov, as described in
the system of records notice (DOT/ALL–
14 FDMS), which can be reviewed at
www.transportation.gov/privacy.
II. Background
On January 15, 2021, FMCSA
published a notice announcing its
decision to renew exemptions for nine
individuals from the hearing standard in
49 CFR 391.41(b)(11) to operate a CMV
in interstate commerce and requested
comments from the public (86 FR 4175).
The public comment period ended on
February 16, 2021, and one comment
was received.
E:\FR\FM\10MRN1.SGM
10MRN1
Agencies
[Federal Register Volume 86, Number 45 (Wednesday, March 10, 2021)]
[Notices]
[Pages 13785-13786]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04946]
=======================================================================
-----------------------------------------------------------------------
OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE
Notice of Product Exclusion Extensions: China's Acts, Policies,
and Practices Related to Technology Transfer, Intellectual Property,
and Innovation
AGENCY: Office of the United States Trade Representative (USTR).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In prior notices, the U.S. Trade Representative modified the
action in the Section 301 investigation of China's acts, policies, and
practices related to technology transfer, intellectual property, and
innovation by excluding from additional duties certain medical-care
products needed to address the COVID-19 pandemic. To support efforts to
combat COVID-19, on December 29, 2020, the U.S. Trade Representative
announced the extension of certain product exclusions on medical-care
and/or COVID response products and further modifications to remove
Section 301 duties from additional medical-care and/or COVID response
products. This notice announces the U.S. Trade Representative's
determination to extend those exclusions.
[[Page 13786]]
DATES: The extensions announced in this notice will extend the product
exclusions through September 30, 2021. U.S. Customs and Border
Protection will issue instructions on entry guidance and
implementation.
FOR FURTHER INFORMATION CONTACT: For general questions about this
notice, contact Associate General Counsel Philip Butler, Assistant
General Counsels Benjamin Allen or Susie Park Hodge, or Director of
Industrial Goods Justin Hoffmann at (202) 395-5725. For specific
questions on customs classification or implementation of the product
exclusions identified in the Annexes to this notice, contact
[email protected].
SUPPLEMENTARY INFORMATION:
A. Background
In the course of this investigation the U.S. Trade Representative
has imposed additional duties on products of China in four tranches.
See 83 FR 28719 (June 20, 2018); 83 FR 40823 (August 16, 2018); 83 FR
47974 (September 21, 2018), as modified by 83 FR 49153 (September 28,
2018); and 84 FR 43304 (August 20, 2019), as modified by 84 FR 69447
(December 18, 2019) and 85 FR 3741 (January 22, 2020).
For each tranche, the U.S. Trade Representative established a
process by which U.S. stakeholders could request the exclusion of
particular products subject to the action. The U.S. Trade
Representative later established a process by which U.S. stakeholders
could request the extension of particular exclusions. Additionally, on
March 25, 2020, the U.S. Trade Representative requested public comments
on possible further modifications to remove Section 301 duties from
additional medical-care products to address the COVID-19 pandemic. 85
FR 16987 (March 25, 2020).
In light of the evolving nature of the battle against COVID-19, on
December 29, 2020, USTR announced the extension of 80 product
exclusions on medical-care and/or COVID response products; further
modifications in the form of 19 product exclusions to remove Section
301 duties from additional medical-care and/or COVID response products;
and that USTR might consider further extensions and/or modifications as
appropriate. See 85 FR 85831 (the December 29 notice).
B. Determination To Extend Certain Exclusions
In light of the continuing efforts to combat COVID-19, the U.S.
Trade Representative has determined that it is inappropriate to allow
the exclusions for certain products to lapse. Accordingly, pursuant to
sections 301(b), 301(c), and 307(a) of the Trade Act of 1974, as
amended, the U.S. Trade Representative has determined to extend the 99
product exclusions included in the December 29 notice through September
30, 2021, as specified in the Annex to this notice. The U.S. Trade
Representative's decision to extend the 99 product exclusions takes
into account public comments previously provided, and the advice of
advisory committees the interagency Section 301 Committee.
As provided in the December 29 notice, the exclusions are available
for any product that meets the description in the product exclusion.
The U.S. Trade Representative may continue to consider further
extensions and/or additional modifications as appropriate.
Annex
Effective with respect to goods entered for consumption, or
withdrawn from warehouse for consumption, on or after 12:01 a.m.
eastern daylight time on April 1, 2021, and before 11:59 p.m.
eastern daylight time on September 30, 2021, each of the article
descriptions of headings 9903.88.62, 9903.88.63, 9903.88.64 and
9903.88.65 of the Harmonized Tariff Schedule of the United States
are modified by deleting ``March 31, 2021,'' and by inserting
``September 30, 2021,'' in lieu thereof.
Greta Peisch,
General Counsel, Office of the United States Trade Representative.
[FR Doc. 2021-04946 Filed 3-9-21; 8:45 am]
BILLING CODE 3290-F0-P